Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This is a 12 week study in which different doses of UK-369,003 will be administered to
patients with a diagnosis of overactive bladder. Patients will complete a series of
questionnaires before treatment, during treatment and after treatment, to assess whether
UK-369,003 has improved their symptoms of overactive bladder and erectile function.